ENGAGEMENT FOR THE FUTURE<\/span><\/p>\n Quality, responsibility and sustainability as guiding principles<\/span><\/p>\n<\/div><\/div><\/div><\/div><\/div> ENGAGEMENT FOR THE FUTURE<\/span><\/p>\n<\/div> The original company was founded in 1977 by Dr. Herbert Rebmann with the goal of producing phospholipids in the high-quality grades and industrial quantities necessary for pharmaceutical applications.<\/p>\n Today, the Ludwigshafen-based Lipoid Group is the world\u2019s only supplier to produce the whole spectrum of natural, hydrogenated, and highly pure synthetic phospholipids. The globally present Lipoid Group employs about 500 people at four production sites \u2013 over 250 at Ludwigshafen and over 160 at Cologne \u2013 and at distribution sites in eight countries.<\/p>\n Phospholipids provide the essential basis for sophisticated parenteral drug delivery systems such as liposomes, mixed micelles, and lipid nanoparticles. Lipoid enabled commercialization of such complex formulations through provision of phospholipids.<\/p>\n These systems play a significant role, for example, in tumor therapeutics and drugs for inhalation. Moreover, Lipoid is prominently involved in Covid-19 mRNA vaccines and vaccines containing adjuvants with its products. In addition, phospholipids from Lipoid have applications in dietary supplements and in high-end cosmetic products.<\/p>\n As a member of the Lipoid Group, Lipoid Kosmetik AG produces top-quality plant extracts and supplies phospholipids from Lipoid for cosmetic applications.<\/p>\n<\/div><\/div><\/div> Consideration of excipients means thinking about phospholipids.<\/em><\/span><\/p>\n Consideration of phospholipids means thinking about Lipoid.<\/em><\/span><\/p><\/h1><\/div><\/div><\/div><\/div><\/div>Pioneer in the field of phospholipids<\/h1><\/div>
\nFor the future, Lipoid will continue to develop high-value and innovative substances, systems, and applications for the benefit of the general public.<\/p>\n